<TABLE>
------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION ------------------------------
FORM 4 Washington, D.C. 20549 OMB Approval
------------------------- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ------------------------------
[ ] Check this box if no OMB Number: 3235-0287
longer subject to Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Expires: September 30, 1998
Section 16. Form 4 Section 17(a) of the Public Utility Holding Company Act of 1935 or Estimated average burden
or Form 5 obligations Section 30(f) of the Investment Company Act of 1940 hours per response.......0.5
may continue. See ------------------------------
Instruction 1(b).
<CAPTION>
(Print or Type Responses)
<S> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker 4. Statement for 6. Relationship of Reporting Person(s)
or Trading Symbol Month/Year to Issuer
(Check all applicable)
HAGLUND, BO OXiGENE Inc. (OXGN) 5/2000 [ ] Director [ ] 10% Owner
------------------------------------ [X] Officer (give [ ] Other
(Last) (First) (Middle) title below) (specify below)
c/o OXiGENE, Inc. Chief Financial Officer
One Copley Place, Suite 602 ---------------------------------------
------------------------------------ -----------------------------------------------------------------------------------------
(Street) 3. I.R.S. Identification 5. If Amendment, 7. Individual or Joint/Group Filing
Number of Reporting Date of (Check Applicable Line)
Person, if an entity Original [X] Form Filed by One Reporting Person
Boston, MA 02116 (Voluntary) (Month/Year) [ ] Form Filed by More than One
------------------------------------ Reporting Person
(City) (State) (Zip)
------------------------------------------------------------------------------------------------------------------------------------
<CAPTION>
TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
<S> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Trans- 3. Transaction 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of
(Instr. 3) action Code (Instr. or Disposed of (D) Securities Form: Indirect
Date 8) (Instr. 3, 4 and 5) Beneficially Direct (D) Beneficial
(Month/ Owned at End or Indirect Ownership
Day/ of Month (I) (Instr. 4)
Year) (Instr. 3 (Instr. 4)
and 4)
------------------------------------------------------------------------------------------------------------------------------------
Code V Amount (A) or (D) Price
------------------------------------------------------------------------------------------------------------------------------------
Common Stock 05/26/00 A 20,000 A $11.75 54,253 D
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
Page 1 of 2
</TABLE>
<PAGE>
<TABLE>
FORM 4 (continued)
<CAPTION>
TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES)
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
------------------------------------------------------------------------------------------------------------------------------------
1. Title 2. Conver- 3. Trans- 4. Trans- 5. Number of 6. Date 7. Title 8. Price 9. Number 10. Owner- 11. Nature of
of sion or action action Derivative Exer- and of of ship Indirect
Deri- Exercise Date Code Securities cisable Amount Deri- Deri- Form Beneficial
vative Price of (Instr. Acquired (A) and Expi- of vative vative of Deri- Ownership
Secu- Deri- (Month/ 8) or Disposed ration Under- Secu- Secu- vative (Instr. 4)
rity vative Day/ of (D) Date lying rity rities Security:
(Instr. Security Year) (Instr. 3, (Month/ Securi- (Instr. Benefi- Direct
3) 4, and 5) Day/ ties 5) cially (D) or
Year) (Instr. Owned Indirect
3 and 4) at End (I)
of (Instr.
Month 4)
(Instr.
4)
------------------------------------------------------------------------------------------------------------------------------------
Code V (A) (D) Date Expir- Title Amount
Exerci- ation or
sable Date Number
of
Shares
------------------------------------------------------------------------------------------------------------------------------------
Common Stock $11.75 05/26/00 A Immed. 09/01/09 Common 10,000 10,000 D
Option Stock
(right to
purchase)(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock $11.75 05/26/00 A Immed. 08/26/01 Common 10,000 10,000 D
Option Stock
(right to
purchase)(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock $11.75 05/26/00 D Immed. 09/01/09 Common 10,000 0
Option Stock
(right to
purchase)(1)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock $11.75 05/26/00 D Immed. 08/26/01 Common 10,000 0
Option Stock
(right to
purchase)(1)
------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:
(1) The Common Stock Options were issued pursuant to the OXiGENE 1996 Stock Incentive Plan, as amended, and in accordance with the
laws of Sweden, were immediately exercisable upon the date of grant, and were exercised on 5/26/00 by executing a promissory
note in the amount of the aggregate exercise price, payable to OXiGENE and secured by the shares of Common Stock purchased by
the reporting person.
** Intentional misstatements or omissions of
facts constitute Federal Criminal Violations.
See 18 U.S.C. and 15 U.S.C. 78ff(a). By: /S/ BO HAGLUND June 12, 2000
------------------------------------- -------------------------
Bo Haglund Date
Note: File three copies of this Form, one of
which must be manually signed. If space
is insufficient, see Instruction 6 for
procedure.
Potential persons who are to respond to the collection of information contained in this form are not required to respond unless form
displays a currently valid OMB number.
Page 2 of 2
</TABLE>
